Pulsed energy treatment for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests a procedure called pulsENDO that uses pulses of energy in the upper intestine to improve blood sugar control in people with type 2 diabetes. It might help you manage your diabetes better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 22 and 75 years old.
- You have had type 2 diabetes for at least 6 months.
- Your blood sugar (HbA1c) is between 7.5% and 10.5% (or 7.5-9.0% if you take 4 diabetes medications).
- Your body mass index (BMI) is between 27 and 40.
- You take 1 to 4 non-insulin diabetes medications, with no changes in the last 12 weeks.
- You have not used insulin for more than 1 month in the past 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
This trial offers continued access to the Endogenex system for people who were in the sham (placebo) group of the ReCET study and have completed their 12-month visit. It tests a device that treats the duodenum to improve blood sugar control.
This study tests a new procedure called pulsENDO, which is done in the first part of the small intestine (the duodenum) to help treat type 2 diabetes. It may be an option for people who were recently diagnosed and have good blood sugar control with little or no diabetes medication.
This trial tests a new endoscopic procedure (pulsENDO) for people with type 2 diabetes and fatty liver disease whose blood sugar remains high despite taking diabetes pills. It aims to see if this treatment can improve blood sugar control and liver health.
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.